Public procurement notice: Contract Notice
Published: 2018-12-08
Buyer: The Common Services Agency (more commonly known as NHS National Services Scotland) (“the Authority")
Country: UK
Contract type: Supplies
Procedure: Open procedure
CPV classification: 33600000: Pharmaceutical products | 33660000
Estimated value: 6227030 GBP
Submission deadline: 2019-01-16
Award criteria: The most economic tender

Technical requirements: This Framework Agreement is for the supply of Clozapine Medicines for 3 testing options to health boards across NHS Scotland.
The goods have been split into two (2) categories, each of which is identified as a “Lot”. The authority intends awarding a single-supplier Framework Agreement on a lot basis.
All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to New Public Bodies (Joint Working) Scotland Act 2014.
Supply of a range of Clozapine Tablets for 3 testing options (Central Laboratory, Local Laboratory and Near Patient Testing) to NHS Scotland, including the loan of patient monitoring machine for blood testing.
Option to extend by a maximum of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.
All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014.
Supply of a range of Clozapine Tablets for 3 testing options (Central laboratory, local laboratory and near patient testing) to NHS Scotland, including the loan of patient monitoring machine for blood testing.
Option to extend by a maximum of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.
Economic operators may be excluded from this competition if they are in breach of any situation referred to in regulation 58 of the Public Contracts (Scotland) Regulations 2015.
(a) potential framework participants must be able to confirm that any products supplied and classed as medicines hold a current and valid UK marketing authorisation that has been approved by the MHRA or EMEA (European Medicines Agency) at the date of the tender submission;
(b) potential framework participants and any sub-contractor(s) must possess valid certification of BS EN ISO 9001 or equivalent;
(c) all tendered Goods must comply with the MHRA best Practice Guidance on Labelling and Packaging and the National Patient Safety Agency (“NPSA") Guidelines on Packaging and Labelling on pack design;
(d) potential framework participants must be able to confirm that any products submitted and classed as medical devices carry CE declaration of conformity, in compliance with the Medical Device Device Directive 93/42/EEC, at the date of the tender submission.
(a) confirmation of existence of a current and valid UK marketing authorisation that has been approved by the MHRA or EMEA (European Medicines Agency) at the date of submission of the tender should be included in the qualification envelope of the itt under the technical and professional ability: quality control;
(b) confirmation of the existence of valid certification of BS EN ISO 9001 or equivalent. Confirmation of such certification should be included in the Qualification Envelope of the ITT under the quality assurance schemes;

Eligibility requirements: Economic operators may be excluded from this competition if they are in breach of any situation referred to in regulation 58 of the Public Contracts (Scotland) Regulations 2015.

Award value: 6227030